Graceway in-licenses Gilead's GS 9191

Gilead Sciences Inc. (NASDAQ:GILD) granted Graceway Pharmaceuticals LLC (Bristol, Tenn.) exclusive, worldwide rights to GS 9191 for topical use. The nucleotide analog recently completed a Phase II tri...